Public Employees Retirement System of Ohio raised its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 2.2% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 88,072 shares of the company’s stock after purchasing an additional 1,854 shares during the quarter. Public Employees Retirement System of Ohio owned approximately 0.10% of IDEXX Laboratories worth $14,217,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. BlackRock Inc. boosted its holdings in shares of IDEXX Laboratories by 1,967.1% during the 1st quarter. BlackRock Inc. now owns 6,427,027 shares of the company’s stock valued at $993,680,000 after buying an additional 6,116,102 shares in the last quarter. Koch Industries Inc. boosted its holdings in shares of IDEXX Laboratories by 44,533.1% during the 2nd quarter. Koch Industries Inc. now owns 1,399,248 shares of the company’s stock valued at $1,391,000 after buying an additional 1,396,113 shares in the last quarter. State Street Corp boosted its holdings in shares of IDEXX Laboratories by 38.6% during the 1st quarter. State Street Corp now owns 3,911,739 shares of the company’s stock valued at $604,793,000 after buying an additional 1,089,880 shares in the last quarter. Janus Henderson Group PLC boosted its holdings in shares of IDEXX Laboratories by 486.4% during the 2nd quarter. Janus Henderson Group PLC now owns 1,131,902 shares of the company’s stock valued at $182,711,000 after buying an additional 938,888 shares in the last quarter. Finally, Old Mutual Global Investors UK Ltd. bought a new stake in shares of IDEXX Laboratories during the 2nd quarter valued at $83,723,000. 87.58% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “IDEXX Laboratories, Inc. (IDXX) Shares Bought by Public Employees Retirement System of Ohio” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2017/10/18/idexx-laboratories-inc-idxx-shares-bought-by-public-employees-retirement-system-of-ohio.html.

A number of analysts have recently commented on IDXX shares. CL King upgraded shares of IDEXX Laboratories from a “neutral” rating to a “buy” rating and set a $200.00 target price on the stock in a report on Friday, July 28th. Zacks Investment Research upgraded shares of IDEXX Laboratories from a “hold” rating to a “buy” rating and set a $186.00 target price on the stock in a report on Wednesday, July 19th. Stifel Nicolaus restated a “buy” rating and set a $185.00 target price on shares of IDEXX Laboratories in a report on Friday, July 14th. BidaskClub cut shares of IDEXX Laboratories from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 5th. Finally, Canaccord Genuity restated a “buy” rating and set a $180.00 target price on shares of IDEXX Laboratories in a report on Friday, October 6th. Two research analysts have rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $174.00.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) traded up 1.184% during midday trading on Wednesday, reaching $161.895. 103,707 shares of the company traded hands. The stock has a market capitalization of $14.13 billion, a P/E ratio of 55.691 and a beta of 0.48. The firm has a 50-day moving average of $156.99 and a 200-day moving average of $160.01. IDEXX Laboratories, Inc. has a 1-year low of $102.45 and a 1-year high of $173.01.

IDEXX Laboratories (NASDAQ:IDXX) last announced its quarterly earnings results on Tuesday, August 1st. The company reported $0.95 earnings per share for the quarter, beating the consensus estimate of $0.85 by $0.10. The company had revenue of $508.90 million during the quarter, compared to analysts’ expectations of $502.44 million. IDEXX Laboratories had a negative return on equity of 473.46% and a net margin of 14.13%. IDEXX Laboratories’s quarterly revenue was up 9.1% on a year-over-year basis. During the same period last year, the business earned $0.74 earnings per share. On average, analysts predict that IDEXX Laboratories, Inc. will post $3.18 earnings per share for the current year.

In related news, Director Lawrence D. Kingsley purchased 2,000 shares of IDEXX Laboratories stock in a transaction that occurred on Thursday, August 3rd. The stock was bought at an average cost of $151.76 per share, for a total transaction of $303,520.00. Following the completion of the transaction, the director now owns 3,344 shares in the company, valued at $507,485.44. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jonathan W. Ayers sold 18,000 shares of IDEXX Laboratories stock in a transaction that occurred on Monday, August 14th. The shares were sold at an average price of $154.91, for a total value of $2,788,380.00. Following the transaction, the chief executive officer now owns 1,043,034 shares of the company’s stock, valued at $161,576,396.94. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 151,734 shares of company stock valued at $23,436,626. 2.77% of the stock is owned by company insiders.

IDEXX Laboratories Company Profile

IDEXX Laboratories, Inc develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.

Institutional Ownership by Quarter for IDEXX Laboratories (NASDAQ:IDXX)

Receive News & Ratings for IDEXX Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories Inc. and related companies with MarketBeat.com's FREE daily email newsletter.